Q Biomed (QBIO)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 25, 2024 09:31 AM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Q Biomed Inc falls in the month of November.
All items in Millions except Per Share data.
11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 0 | 0 | 0 | 0 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 0 | 0 | 0 | 0 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 3 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 4 | 1 | 1 | 1 |
Liabilities & Shareholders Equity | 11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 3 | 0 | 3 |
Accounts Payable | NA | 2 | 1 | 1 | 1 |
Current Portion Long-Term Debt | NA | 4 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 2 | 1 | 1 | 1 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 8 | 5 | 2 | 5 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 8 | 5 | 2 | 6 |
Shareholders Equity | 11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 5 | 6 | 7 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 56 | 53 | 48 | 37 |
Retained Earnings | NA | -66 | -64 | -56 | -42 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -5 | -5 | -1 | -5 |
Total Liabilities & Shareholder's Equity | NA | 4 | 1 | 1 | 1 |
Total Common Equity | 0 | -10 | -11 | -8 | -5 |
Shares Outstanding | 145.10 | 91.90 | 28.90 | 23.80 | 19.20 |
Book Value Per Share | 0.00 | -0.11 | -0.37 | -0.34 | -0.26 |
Fiscal Year End for Q Biomed Inc falls in the month of November.
All items in Millions except Per Share data.
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,999 | -99,999 | -99,999 |
Receivables | NA | NA | NA | NA | NA |
Notes Receivable | NA | NA | NA | NA | NA |
Inventories | NA | NA | NA | NA | NA |
Other Current Assets | NA | NA | NA | NA | NA |
Total Current Assets | NA | NA | NA | NA | NA |
Net Property & Equipment | NA | NA | NA | NA | NA |
Investments & Advances | NA | NA | NA | NA | NA |
Other Non-Current Assets | NA | NA | NA | NA | NA |
Deferred Charges | NA | NA | NA | NA | NA |
Intangibles | NA | NA | NA | NA | NA |
Deposits & Other Assets | NA | NA | NA | NA | NA |
Total Assets | NA | NA | NA | NA | NA |
Liabilities & Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | NA | NA |
Accounts Payable | NA | NA | NA | NA | NA |
Current Portion Long-Term Debt | NA | NA | NA | NA | NA |
Current Portion Capital Leases | NA | NA | NA | NA | NA |
Accrued Expenses | NA | NA | NA | NA | NA |
Income Taxes Payable | NA | NA | NA | NA | NA |
Other Current Liabilities | NA | NA | NA | NA | NA |
Total Current Liabilities | NA | NA | NA | NA | NA |
Mortgages | NA | NA | NA | NA | NA |
Deferred Taxes/Income | NA | NA | NA | NA | NA |
Convertible Debt | NA | NA | NA | NA | NA |
Long-Term Debt | NA | NA | NA | NA | NA |
Non-Current Capital Leases | NA | NA | NA | NA | NA |
Other Non-Current Liabilities | NA | NA | NA | NA | |
Minority Interest (Liabilities) | NA | NA | NA | NA | NA |
Total Liabilities | NA | NA | NA | NA | NA |
Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | NA | NA |
Common Stock (Par) | NA | NA | NA | NA | NA |
Capital Surplus | NA | NA | NA | NA | NA |
Retained Earnings | NA | NA | NA | NA | NA |
Other Equity | NA | NA | NA | NA | NA |
Treasury Stock | NA | NA | NA | NA | NA |
Total Shareholder's Equity | NA | NA | NA | NA | NA |
Total Liabilities & Shareholder's Equity | NA | NA | NA | NA | NA |
Total Common Equity | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding | 145.10 | 145.10 | 145.10 | 145.10 | 145.10 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |